RSH 7.41% 2.9¢ respiri limited

Ann: Preliminary Final Report, page-26

  1. 1,270 Posts.
    lightbulb Created with Sketch. 587
    Appreciate your input.
    Yeah sales are the ultimate end result that it needs to be measured on.
    The other endorsements i mentioned above are a key part of any medical products’ journey from “development to sales”. So they need to be ticked off for a product/drug to become part of the “standard of care” is my assumption. Then you can expect meaningful adoption and therefore “sales”.

    So I was just getting a gauge on your thoughts. Thanks again guys.
    Last edited by Yenom23: 27/09/21
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.9¢
Change
0.002(7.41%)
Mkt cap ! $37.25M
Open High Low Value Volume
2.7¢ 2.9¢ 2.7¢ $5.276K 192.2K

Buyers (Bids)

No. Vol. Price($)
1 500000 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 147741 2
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.